3,6,6-Trimethyl-6,7-dihydro-1H-indol-4(5H)-one, 95.0%, 250mg

2-Amino-2-cyclohexylacetic acid, 95.0%, 25g

2-(m-Tolyl)isonicotinic acid, 96%, 250mg

4-(4-(Trifluoromethyl)phenoxy)benzaldehyde, 95.0%, 100mg

4-(Piperazin-1-yl)butan-1-ol oxalate, 98%, 100mg

Nicotinic Acid [Matrix for MALDI-TOF/MS]>99.5%(HPLC)(T)1g

cis-4-Amino-1-methylcyclohexanol, 95.0%, 1g

3,6-Dimethyloct-4-yne-3,6-diol, 98%, 100g

6-Amino-1-benzyl-5-bromopyrimidine-2,4(1H,3H)-dione, 95.0%, 5g

2-(4-((3-Methoxybenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

2-Amino-3,4-dimethylpyridine, 95.0%, 1g

3-BROMOQUINOLINE-6-CARBOXYLIC ACID, 95.0%, 1g

5-Nitrobenzo[d]thiazole-2-carbonitrile, 95.0%, 5g